{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T06:48:38Z","timestamp":1761288518055,"version":"build-2065373602"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1038\/s41401-025-01597-5","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T04:39:29Z","timestamp":1750394369000},"page":"2951-2962","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SMURF2 inhibition attenuates cardiac hypertrophy through blocking ubiquitination degradation of AXIN1"],"prefix":"10.1038","volume":"46","author":[{"given":"Ying","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi-yao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia-meng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-qing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liu-liu","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-ping","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,20]]},"reference":[{"key":"1597_CR1","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1038\/s41401-021-00828-9","volume":"43","author":"S Zhao","year":"2022","unstructured":"Zhao S, Song TY, Wang ZY, Gao J, Cao JW, Hu LL, et al. S-nitrosylation of Hsp90 promotes cardiac hypertrophy in mice through GSK3\u03b2 signaling. Acta Pharmacol Sin. 2022;43:1979\u201388.","journal-title":"Acta Pharmacol Sin"},{"key":"1597_CR2","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","volume":"15","author":"M Nakamura","year":"2018","unstructured":"Nakamura M, Sadoshima J. Mechanisms of physiological and pathological cardiac hypertrophy. Nat Rev Cardiol. 2018;15:387\u2013407.","journal-title":"Nat Rev Cardiol"},{"key":"1597_CR3","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1093\/eurheartj\/ehn156","volume":"29","author":"MR Macdonald","year":"2008","unstructured":"Macdonald MR, Petrie MC, Hawkins NM, Petrie JR, Fisher M, Mckelvie R, et al. Diabetes, left ventricular systolic dysfunction, and chronic heart failure. Eur Heart J. 2008;29:1224\u201340.","journal-title":"Eur Heart J"},{"key":"1597_CR4","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1161\/CIRCRESAHA.123.323356","volume":"135","author":"Y Wang","year":"2024","unstructured":"Wang Y, Zhang M, Wang R, Lin J, Ma Q, Guo H, et al. Therapeutic inhibition of LincRNA-p21 protects against cardiac hypertrophy. Circ Res. 2024;135:434\u201349.","journal-title":"Circ Res"},{"key":"1597_CR5","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1161\/CIRCRESAHA.114.300507","volume":"114","author":"T Oka","year":"2014","unstructured":"Oka T, Akazawa H, Naito AT, Komuro I. Angiogenesis and cardiac hypertrophy: maintenance of cardiac function and causative roles in heart failure. Circ Res. 2014;114:565\u201371.","journal-title":"Circ Res"},{"key":"1597_CR6","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1161\/CIRCRESAHA.122.321849","volume":"132","author":"B Ye","year":"2023","unstructured":"Ye B, Zhou H, Chen Y, Luo W, Lin W, Zhao Y, et al. USP25 ameliorates pathological cardiac hypertrophy by stabilizing SERCA2a in cardiomyocytes. Circ Res. 2023;132:465\u201380.","journal-title":"Circ Res"},{"key":"1597_CR7","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1093\/cvr\/cvaa266","volume":"117","author":"Q Wang","year":"2021","unstructured":"Wang Q, Wang Y, West TM, Liu Y, Reddy GR, Barbagallo F, et al. Carvedilol induces biased \u03b21 adrenergic receptor-nitric oxide synthase 3-cyclic guanylyl monophosphate signalling to promote cardiac contractility. Cardiovasc Res. 2021;117:2237\u201351.","journal-title":"Cardiovasc Res"},{"key":"1597_CR8","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.jchf.2022.06.005","volume":"10","author":"T Kahlon","year":"2022","unstructured":"Kahlon T, Carlisle S, Otero Mostacero D, Williams N, Trainor P, Defilippis AP. Angiotensinogen: more than its downstream products: evidence from population studies and novel therapeutics. JACC Heart Fail 2022;10:699\u2013713.","journal-title":"JACC Heart Fail"},{"key":"1597_CR9","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1161\/CIRCULATIONAHA.121.055841","volume":"145","author":"P Wang","year":"2022","unstructured":"Wang P, Xu S, Xu J, Xin Y, Lu Y, Zhang H, et al. Elevated MCU expression by CaMKII\u03b4B limits pathological cardiac remodeling. Circulation. 2022;145:1067\u201383.","journal-title":"Circulation"},{"key":"1597_CR10","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1161\/CIRCRESAHA.119.315432","volume":"125","author":"Y Cao","year":"2019","unstructured":"Cao Y, Xu C, Ye J, He Q, Zhang X, Jia S, et al. Miro2 regulates inter-mitochondrial communication in the heart and protects against TAC-induced cardiac dysfunction. Circ Res. 2019;125:728\u201343.","journal-title":"Circ Res"},{"key":"1597_CR11","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1161\/CIRCRESAHA.109.214346","volume":"106","author":"AT Naito","year":"2010","unstructured":"Naito AT, Okada S, Minamino T, Iwanaga K, Liu ML, Sumida T, et al. Promotion of CHIP-mediated p53 degradation protects the heart from ischemic injury. Circ Res. 2010;106:1692\u2013702.","journal-title":"Circ Res"},{"key":"1597_CR12","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1161\/CIRCRESAHA.115.307644","volume":"117","author":"CC Glembotski","year":"2015","unstructured":"Glembotski CC. Breaking down the COP9 Signalsome in the heart: how inactivating a protein ubiquitin ligase increases protein ubiquitylation and protects the heart. Circ Res. 2015;117:914\u20136.","journal-title":"Circ Res"},{"key":"1597_CR13","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1161\/CIRCRESAHA.119.316444","volume":"126","author":"N Xu","year":"2020","unstructured":"Xu N, Gulick J, Osinska H, Yu Y, Mclendon PM, Shay-Winkler K, et al. Ube2v1 positively regulates protein aggregation by modulating ubiquitin proteasome system performance partially through K63 ubiquitination. Circ Res. 2020;126:907\u201322.","journal-title":"Circ Res"},{"key":"1597_CR14","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1161\/CIRCRESAHA.109.208801","volume":"106","author":"MS Willis","year":"2010","unstructured":"Willis MS, Townley-Tilson WH, Kang EY, Homeister JW, Patterson C. Sent to destroy: the ubiquitin proteasome system regulates cell signaling and protein quality control in cardiovascular development and disease. Circ Res. 2010;106:463\u201378.","journal-title":"Circ Res"},{"key":"1597_CR15","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1161\/CIRCULATIONAHA.121.054827","volume":"144","author":"D Zhao","year":"2021","unstructured":"Zhao D, Zhong G, Li J, Pan J, Zhao Y, Song H, et al. Targeting E3 ubiquitin ligase WWP1 prevents cardiac hypertrophy through destabilizing DVL2 via inhibition of K27-linked ubiquitination. Circulation. 2021;144:694\u2013711.","journal-title":"Circulation"},{"key":"1597_CR16","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1161\/CIRCRESAHA.124.324872","volume":"136","author":"X Tang","year":"2025","unstructured":"Tang X, Liu X, Sha X, Zhang Y, Zu Y, Fan Q, et al. NEDD4-mediated GSNOR degradation aggravates cardiac hypertrophy and dysfunction. Circ Res. 2025;136:422\u201338.","journal-title":"Circ Res"},{"key":"1597_CR17","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.semcancer.2019.12.023","volume":"67","author":"L Fu","year":"2020","unstructured":"Fu L, Cui CP, Zhang X, Zhang L. The functions and regulation of Smurfs in cancers. Semin Cancer Biol. 2020;67:102\u201316.","journal-title":"Semin Cancer Biol"},{"key":"1597_CR18","doi-asserted-by":"crossref","unstructured":"Ni C, Chen Y, Xu Y, Zhao J, Li Q, Xiao C, et al. Flavin containing monooxygenase 2 prevents cardiac fibrosis via CYP2J3-SMURF2 axis. Circ Res. 2022; 101161circresaha122320538.","DOI":"10.1161\/CIRCRESAHA.122.320538"},{"key":"1597_CR19","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/s12276-021-00631-w","volume":"53","author":"Y Huang","year":"2021","unstructured":"Huang Y, Xu Y, Feng S, He P, Sheng B, Ni J. miR-19b enhances osteogenic differentiation of mesenchymal stem cells and promotes fracture healing through the WWP1\/Smurf2-mediated KLF5\/\u03b2-catenin signaling pathway. Exp Mol Med. 2021;53:973\u201385.","journal-title":"Exp Mol Med"},{"key":"1597_CR20","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","volume":"169","author":"R Nusse","year":"2017","unstructured":"Nusse R, Clevers H. Wnt\/\u03b2-catenin signaling, disease, and emerging therapeutic modalities. Cell. 2017;169:985\u201399.","journal-title":"Cell"},{"key":"1597_CR21","doi-asserted-by":"publisher","first-page":"16736","DOI":"10.1073\/pnas.1412152111","volume":"111","author":"T Mund","year":"2014","unstructured":"Mund T, Lewis MJ, Maslen S, Pelham HR. Peptide and small molecule inhibitors of HECT-type ubiquitin ligases. Proc Natl Acad Sci USA. 2014;111:16736\u201341.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1597_CR22","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.cell.2012.05.002","volume":"149","author":"VS Li","year":"2012","unstructured":"Li VS, Ng SS, Boersema PJ, Low TY, Karthaus WR, Gerlach JP, et al. Wnt signaling through inhibition of \u03b2-catenin degradation in an intact Axin1 complex. Cell. 2012;149:1245\u201356.","journal-title":"Cell"},{"key":"1597_CR23","doi-asserted-by":"publisher","first-page":"795","DOI":"10.2337\/db21-0506","volume":"71","author":"X Chen","year":"2022","unstructured":"Chen X, Li Y, Yuan X, Yuan W, Li C, Zeng Y, et al. Methazolamide attenuates the development of diabetic cardiomyopathy by promoting \u03b2-catenin degradation in type 1 diabetic mice. Diabetes. 2022;71:795\u2013811.","journal-title":"Diabetes"},{"key":"1597_CR24","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/cr.2016.39","volume":"26","author":"KN Swatek","year":"2016","unstructured":"Swatek KN, Komander D. Ubiquitin modifications. Cell Res. 2016;26:399\u2013422.","journal-title":"Cell Res"},{"key":"1597_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02046-3","volume":"23","author":"F Liu","year":"2024","unstructured":"Liu F, Chen J, Li K, Li H, Zhu Y, Zhai Y, et al. Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches. Mol Cancer. 2024;23:148.","journal-title":"Mol Cancer"},{"key":"1597_CR26","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.tibs.2019.08.004","volume":"44","author":"F Bernassola","year":"2019","unstructured":"Bernassola F, Chillemi G, Melino G. HECT-type E3 ubiquitin ligases in cancer. Trends Biochem Sci. 2019;44:1057\u201375.","journal-title":"Trends Biochem Sci"},{"key":"1597_CR27","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1038\/nm.3739","volume":"20","author":"D Popovic","year":"2014","unstructured":"Popovic D, Vucic D, Dikic I. Ubiquitination in disease pathogenesis and treatment. Nat Med. 2014;20:1242\u201353.","journal-title":"Nat Med"},{"key":"1597_CR28","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1161\/CIRCRESAHA.121.318866","volume":"130","author":"J Liu","year":"2022","unstructured":"Liu J, Li W, Deng KQ, Tian S, Liu H, Shi H, et al. The E3 ligase TRIM16 is a key suppressor of pathological cardiac hypertrophy. Circ Res. 2022;130:1586\u2013600.","journal-title":"Circ Res"},{"key":"1597_CR29","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1161\/CIRCRESAHA.123.324202","volume":"135","author":"MA Lorenzana-Carrillo","year":"2024","unstructured":"Lorenzana-Carrillo MA, Tejay S, Nanoa J, Huang G, Liu Y, Haromy A, et al. TRIM35 monoubiquitinates H2B in cardiac cells, implications for heart failure. Circ Res. 2024;135:301\u201313.","journal-title":"Circ Res"},{"key":"1597_CR30","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1161\/CIRCRESAHA.122.321725","volume":"132","author":"SR Nayakanti","year":"2023","unstructured":"Nayakanti SR, Friedrich A, Sarode P, Jafari L, Maroli G, Boehm M, et al. Targeting Wnt-\u00df-catenin-FOSL signaling ameliorates right ventricular remodeling. Circ Res. 2023;132:1468\u201385.","journal-title":"Circ Res"},{"key":"1597_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00840-w","volume":"8","author":"FL Xiang","year":"2017","unstructured":"Xiang FL, Fang M, Yutzey KE. Loss of \u03b2-catenin in resident cardiac fibroblasts attenuates fibrosis induced by pressure overload in mice. Nat Commun. 2017;8:712.","journal-title":"Nat Commun"},{"key":"1597_CR32","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1161\/CIRCRESAHA.110.223768","volume":"107","author":"MW Bergmann","year":"2010","unstructured":"Bergmann MW. WNT signaling in adult cardiac hypertrophy and remodeling: lessons learned from cardiac development. Circ Res. 2010;107:1198\u2013208.","journal-title":"Circ Res"},{"key":"1597_CR33","doi-asserted-by":"publisher","first-page":"36420","DOI":"10.1074\/jbc.M110.137471","volume":"285","author":"S Kim","year":"2010","unstructured":"Kim S, Jho EH. The protein stability of Axin, a negative regulator of Wnt signaling, is regulated by Smad ubiquitination regulatory factor 2 (Smurf2). J Biol Chem. 2010;285:36420\u20136.","journal-title":"J Biol Chem"},{"key":"1597_CR34","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.116.003010","volume":"9","author":"N Hou","year":"2016","unstructured":"Hou N, Ye B, Li X, Margulies KB, Xu H, Wang X, et al. Transcription factor 7-like 2 mediates canonical Wnt\/\u03b2-catenin signaling and c-Myc upregulation in heart failure. Circ Heart Fail. 2016;9:e003010.","journal-title":"Circ Heart Fail"},{"key":"1597_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103466","volume":"79","author":"L Pan","year":"2025","unstructured":"Pan L, Huang C, Jin X, Wu J, Jin K, Lin J, et al. Cardiac secreted HSP90\u03b1 exacerbates pressure overload myocardial hypertrophy and heart failure. Redox Biol. 2025;79:103466.","journal-title":"Redox Biol"},{"key":"1597_CR36","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.3389\/fimmu.2019.02147","volume":"10","author":"PC Tseng","year":"2019","unstructured":"Tseng PC, Kuo CF, Cheng MH, Wan SW, Lin CF, Chang CP, et al. HECT E3 ubiquitin ligase-regulated Txnip degradation facilitates TLR2-mediated inflammation during Group A Streptococcal infection. Front Immunol. 2019;10:2147.","journal-title":"Front Immunol"},{"key":"1597_CR37","doi-asserted-by":"publisher","first-page":"7791","DOI":"10.3390\/ijms22157791","volume":"22","author":"S Kim","year":"2021","unstructured":"Kim S, Lee W, Cho K. P62 links the autophagy pathway and the ubiquitin-proteasome system in endothelial cells during atherosclerosis. Int J Mol Sci. 2021;22:7791.","journal-title":"Int J Mol Sci"},{"key":"1597_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.nlm.2019.107135","volume":"167","author":"J Redondo","year":"2020","unstructured":"Redondo J, Popik B, Casagrande M, Silva MO, Quillfeldt JA, De Oliveira Alvares L, et al. Hippocampal HECT E3 ligase inhibition facilitates consolidation, retrieval, and reconsolidation, and inhibits extinction of contextual fear memory. Neurobiol Learn Mem. 2020;167:107135.","journal-title":"Neurobiol Learn Mem"},{"key":"1597_CR39","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1056\/NEJMoa1002659","volume":"363","author":"CY Ho","year":"2010","unstructured":"Ho CY, L\u00f3pez B, Coelho-Filho OR, Lakdawala NK, Cirino AL, Jarolim P, et al. Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. N Engl J Med. 2010;363:552\u201363.","journal-title":"N Engl J Med"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01597-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01597-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01597-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T06:42:48Z","timestamp":1761288168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01597-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,20]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["1597"],"URL":"https:\/\/doi.org\/10.1038\/s41401-025-01597-5","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"type":"print","value":"1671-4083"},{"type":"electronic","value":"1745-7254"}],"subject":[],"published":{"date-parts":[[2025,6,20]]},"assertion":[{"value":"5 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}